AGP Executive Report
Last update: 10 hours agoNew MS treatment pathway: Oculis says the FDA gave positive pre-IND feedback for Privosegtor, allowing its data to be reused for an IND application targeting acute multiple sclerosis relapses, with an IND planned for Q4 2026. Chronic liver disease focus: A Europe-wide push for a “functional cure” for hepatitis B highlights that millions in Iceland and across the EU/EEA are chronically infected and still need better options beyond today’s virus-suppressing drugs. Genetics and pain care: A major study links 26 genome regions to fibromyalgia risk, strengthening the case for a biological basis tied to brain and nerve function—important for patients who’ve long been dismissed. Public health policy (regionally relevant): Sweden is adding chickenpox vaccination to its national program and making varicella reporting mandatory from Nov 1, 2026, aiming to close surveillance gaps for elimination. Local safety update: Police report a unusually calm start to Þjóðhátíð in the Westman Islands, with one Coast Guard helicopter evacuation for a leg injury and few other serious incidents. Health-adjacent lifestyle: Iceland’s wider region is mentioned in eclipse viewing guidance for Aug 12, with safe-glasses reminders for anyone planning to watch.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
